News | Artificial Intelligence | November 06, 2023

Two oral presentations and five ePosters accepted by the RSNA: presenting AI advancements for chest radiograph reporting efficiency and breast cancer risk assessment 

Two oral presentations and five ePosters accepted by the RSNA: presenting AI advancements for chest radiograph reporting efficiency and breast cancer risk assessment

(from left to right) Lunit's AI-powered chest X-ray analysis solution 'Lunit INSIGHT CXR' and AI-powered mammography analysis solution 'Lunit INSIGHT MMG'


November 6, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, is set to unveil seven significant abstracts at the Radiological Society of North America (RSNA) 2023 Annual Meeting, taking place from November 26 to November 30 in Chicago. 

The highlighted abstracts for RSNA 2023 include: 

  • an oral presentation: Lunit's AI model redefines the efficiency of chest radiograph reporting by combining new and existing AI algorithms to filter normal chest radiographs and act as a safety net to reduce radiologists’ workload. 
  • an oral presentation: in collaboration with a Swedish research group, the accuracy and robustness metrics of Lunit INSIGHT MMG were assessed in comparison to radiologists. 
  • an ePoster: Lunit's novel, predictive AI model goes beyond traditional mammographic density by investigating mammographic parenchymal patterns and longitudinal changes as predictive markers for breast cancer risk. 
  • an ePoster: comparison of the diagnostic accuracy of radiologists with and without Lunit’s AI-powered breast cancer screening solution. 
  • an ePoster: assessment of the value of supplemental breast ultrasound and Lunit’s AI in screening mammography for women with dense breasts. 
  • an ePoster: assessment of the false-negative results of Lunit’s AI-based CADe/x in mammograms for invasive breast cancers, considering molecular subtypes. 

"Lunit is consistently backing the effectiveness of the Lunit INSIGHT suite by participating in RSNA and unveiling a spectrum of innovative research results each year at RSNA since 2016. We remain dedicated to enhancing our solutions, steering the field towards a new era of chest and breast cancer screening," said Brandon Suh, CEO of Lunit. 

Beyond abstract presentations, Lunit will further showcase its AI solutions onsite by setting up a dedicated booth (#4165) at the AI Showcase section. Visitors will have the opportunity to experience firsthand how Lunit’s AI solutions are contributing to more than 2000 medical institutions worldwide and addressing the most significant global health challenges. 

For more information: www.lunit.com 

 

Find more RSNA23 conference coverage here 

 

Related content: 

Lunit SCOPE IO Enhances Breast Cancer Analysis and Treatment by Accurately Assessing Tumor-Infiltrating Lymphocytes 

Lunit's AI-Powered Mammography Analysis Solution Achieves Comparable Diagnostic Performance with Human Readers 

STUDY VALIDATES LUNIT AI AS A GAME-CHANGER, POISED TO REPLACE ONE HUMAN READER IN BREAST CANCER SCREENING 


Related Content

News | Magnetic Resonance Imaging (MRI)

July 2, 2025 — Philips has received FDA 510(k) clearance for SmartSpeed Precise[1] MR’s latest deep learning ...

Time July 03, 2025
arrow
News | Ultrasound Imaging

July 1, 2025 — UPDATE: The final paper is now available at: JMIR AI - ChatGPT-4–Driven Liver Ultrasound Radiomics ...

Time July 01, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

June 26, 2025 — Siemens Healthineers has received Food and Drug Administration clearance for the Magnetom Flow.Ace, its ...

Time June 26, 2025
arrow
News | Prostate Cancer

June 26, 2025 – Quibim, a global provider of quantitative medical imaging solutions, has launched AI-QUAL, a new feature ...

Time June 26, 2025
arrow
News | Breast Imaging

June 25, 2025 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time June 25, 2025
arrow
News | Bone Densitometry Systems

June 19, 2025 — Naitive Technologies has published results demonstrating the diagnostic performance of its AI-powered ...

Time June 18, 2025
arrow
News | Lung Imaging

June 18, 2025 — Exo recently announced that now included on its Exo Iris is the first ever FDA 510(k) cleared AI for ...

Time June 18, 2025
arrow
News | Digital Pathology

June 11, 2025 — Diagnostic laboratory leaders view digital pathology and artificial intelligence (AI) as pivotal to ...

Time June 12, 2025
arrow
News | Lung Imaging

June 11, 2025 — To prepare healthcare workforces and providers for an AI-driven future, Qure.ai has expanded its Global ...

Time June 11, 2025
arrow
News | Radiology Imaging

June 10, 2025 — CIVIE has announced the official launch of RadPod, an AI-driven, on-demand radiology platform designed ...

Time June 10, 2025
arrow
Subscribe Now